ORBi: Hiligsmann Mickaël - Cost-effectiveness of denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women

Reference : Cost-effectiveness of denosumab compared with generic alendronate in the treatment of po...


	Document type :	Scientific congresses and symposiums : Paper published in a journal
	Discipline(s) :	Human health sciences : Endocrinology, metabolism & nutrition Business & economic sciences : Special economic topics (health, labor, transportation…)
	To cite this reference:	http://hdl.handle.net/2268/70150

Title :	Cost-effectiveness of denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women
Language :	English
Author, co-author :	Hiligsmann, Mickaël [Université de Liège - ULg > HEC-Ecole de gestion de l'ULg > > >]
	Reginster, Jean-Yves [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Publication date :	Nov-2010
Journal title :	Value in Health
Publisher :	Blackwell Publishing
Volume :	13
Issue/season :	7
Pages :	A309
On invitation :	No
Audience :	International
ISSN :	1098-3015
e-ISSN :	1524-4733
City :	Oxford
Country :	United Kingdom
Event name :	ISPOR 13th Annual European Congress
Event date :	du 6 novembre 2010 au 9 novembre 2009
Event organizer :	ISPOR
Event place (city) :	Prague
Event country :	République Tchèque
Research units :	Unité de Recherches en Pharmaco-Economie (ECOHEALTH)
Target :	Researchers ; Professionals
Permalink :	http://hdl.handle.net/2268/70150

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	Abstract_ISPOR2010.pdf		Author postprint	14.84 kB	Request copy

Additional material(s):

	File	Commentary	Version	Size	Access
Restricted access	ISPOR_2010_Dmab.pdf	Présentation Poster	-	618.71 kB	Request copy

All documents in ORBi are protected by a user license.